Ameriprise Financial Inc. acquired a new position in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 54,375 shares of the company's stock, valued at approximately $248,000.
A number of other institutional investors have also modified their holdings of AVAH. KLP Kapitalforvaltning AS acquired a new position in Aveanna Healthcare during the 4th quarter valued at about $35,000. Tower Research Capital LLC TRC raised its stake in Aveanna Healthcare by 662.2% during the 4th quarter. Tower Research Capital LLC TRC now owns 7,889 shares of the company's stock valued at $36,000 after purchasing an additional 6,854 shares during the period. Catalyst Funds Management Pty Ltd increased its stake in shares of Aveanna Healthcare by 321.4% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company's stock worth $54,000 after acquiring an additional 9,000 shares during the last quarter. Sagespring Wealth Partners LLC acquired a new position in Aveanna Healthcare during the fourth quarter worth $57,000. Finally, Arizona State Retirement System acquired a new stake in shares of Aveanna Healthcare in the fourth quarter valued at about $64,000. Institutional investors and hedge funds own 87.96% of the company's stock.
Wall Street Analysts Forecast Growth
AVAH has been the topic of several recent analyst reports. Truist Financial reduced their target price on shares of Aveanna Healthcare from $6.00 to $5.50 and set a "hold" rating on the stock in a research note on Friday, April 11th. UBS Group raised their price target on Aveanna Healthcare from $4.50 to $5.00 and gave the stock a "sell" rating in a research report on Friday, May 9th.
Get Our Latest Analysis on AVAH
Insider Transactions at Aveanna Healthcare
In other Aveanna Healthcare news, major shareholder J.H. Whitney Equity Partners V sold 1,560,700 shares of Aveanna Healthcare stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $5.36, for a total transaction of $8,365,352.00. Following the sale, the insider now directly owns 29,640,756 shares of the company's stock, valued at approximately $158,874,452.16. The trade was a 5.00% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Robert M. Williams, Jr. sold 91,061 shares of the company's stock in a transaction that occurred on Thursday, May 8th. The shares were sold at an average price of $5.84, for a total value of $531,796.24. Following the completion of the transaction, the insider now directly owns 545,330 shares in the company, valued at $3,184,727.20. This trade represents a 14.31% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 4,887,612 shares of company stock valued at $26,269,057. 7.80% of the stock is currently owned by company insiders.
Aveanna Healthcare Stock Performance
Shares of AVAH remained flat at $5.51 during trading hours on Friday. 543,253 shares of the company were exchanged, compared to its average volume of 314,751. The stock has a market cap of $1.07 billion, a P/E ratio of -16.21 and a beta of 2.03. Aveanna Healthcare Holdings Inc. has a one year low of $2.32 and a one year high of $6.19. The stock has a 50 day moving average price of $5.08 and a two-hundred day moving average price of $4.94.
About Aveanna Healthcare
(
Free Report)
Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.
Featured Articles

Before you consider Aveanna Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.
While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.